Serene S Paul1, Leland E Dibble2, Genevieve N Olivier2, Christopher Walter3, Kevin Duff4, Sydney Y Schaefer5. 1. Department of Physical Therapy and Athletic Training, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA; Discipline of Physiotherapy, Faculty of Health Sciences, The University of Sydney, 75 East St, Lidcombe, NSW, 2141, Australia. Electronic address: serene.paul@sydney.edu.au. 2. Department of Physical Therapy and Athletic Training, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA. 3. Department of Physical Therapy and Athletic Training, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA; Department of Physical Therapy, University of Arkansas for Medical Sciences, 1125 N College Ave, Fayetteville, AR, 72703, USA. 4. Center for Alzheimer's Care, Imaging & Research, Department of Neurology, University of Utah, 650 Komas Dr 106A, Salt Lake City, UT, 84108, USA. 5. Department of Physical Therapy and Athletic Training, University of Utah, 520 Wakara Way, Salt Lake City, UT, 84108, USA; Department of Biological and Health Systems Engineering, Arizona State University, 501 E Tyler Mall, MC 9709, Tempe, AZ, 85287, USA.
Abstract
BACKGROUND:Dopamine replacement medication has positive effects on existing motor skills for people with Parkinson disease (PD), but may have detrimental effects on the learning of motor skills necessary for effective rehabilitation according to the dopamine overdose hypothesis. OBJECTIVES: This study aimed to determine whether dopamine replacement medication (i.e. levodopa) affects: learning of a novel upper extremity task, decrements in skill following withdrawal of practice, the rate of learning, and the transfer of movement skill to untrained upper extremity tasks compared to training "off" medication, in people with PD. METHODS:Participants with mild-moderate PD (Hoehn and Yahr stage 2) were randomized to train "on" (n = 12) or "off" (n = 11) levodopa medication. Participants practiced 10 blocks of five trials of a functional motor task with their non-dominant upper extremity over three consecutive days (acquisition period), followed by a single block of five trials two and nine days later. Participants were also assessed "on" levodopa with two transfer tasks (the nine-hole peg test and a functional dexterity task) prior to any practice and nine days after the end of the acquisition period. RESULTS:Participants who practiced "on" levodopa medication learned the upper extremity task to a greater extent that those who practiced "off" medication, as determined by retained performance two days after practice. Skill decrement and skill transfer were not significantly different between groups. Rate of learning was unable to be modelled in this sample. CONCLUSIONS:Levodopa medication improved the learning of an upper extremity task in people with mild-moderate PD.
RCT Entities:
BACKGROUND:Dopamine replacement medication has positive effects on existing motor skills for people with Parkinson disease (PD), but may have detrimental effects on the learning of motor skills necessary for effective rehabilitation according to the dopamineoverdose hypothesis. OBJECTIVES: This study aimed to determine whether dopamine replacement medication (i.e. levodopa) affects: learning of a novel upper extremity task, decrements in skill following withdrawal of practice, the rate of learning, and the transfer of movement skill to untrained upper extremity tasks compared to training "off" medication, in people with PD. METHODS:Participants with mild-moderate PD (Hoehn and Yahr stage 2) were randomized to train "on" (n = 12) or "off" (n = 11) levodopa medication. Participants practiced 10 blocks of five trials of a functional motor task with their non-dominant upper extremity over three consecutive days (acquisition period), followed by a single block of five trials two and nine days later. Participants were also assessed "on" levodopa with two transfer tasks (the nine-hole peg test and a functional dexterity task) prior to any practice and nine days after the end of the acquisition period. RESULTS:Participants who practiced "on" levodopa medication learned the upper extremity task to a greater extent that those who practiced "off" medication, as determined by retained performance two days after practice. Skill decrement and skill transfer were not significantly different between groups. Rate of learning was unable to be modelled in this sample. CONCLUSIONS:Levodopa medication improved the learning of an upper extremity task in people with mild-moderate PD.
Authors: Samyra H J Keus; Bastiaan R Bloem; Erik J M Hendriks; Alexandra B Bredero-Cohen; Marten Munneke Journal: Mov Disord Date: 2007-03-15 Impact factor: 10.338
Authors: Serene S Paul; Sydney Y Schaefer; Genevieve N Olivier; Christopher S Walter; Keith R Lohse; Leland E Dibble Journal: Neurorehabil Neural Repair Date: 2018-11-09 Impact factor: 3.919
Authors: Christopher G Goetz; Barbara C Tilley; Stephanie R Shaftman; Glenn T Stebbins; Stanley Fahn; Pablo Martinez-Martin; Werner Poewe; Cristina Sampaio; Matthew B Stern; Richard Dodel; Bruno Dubois; Robert Holloway; Joseph Jankovic; Jaime Kulisevsky; Anthony E Lang; Andrew Lees; Sue Leurgans; Peter A LeWitt; David Nyenhuis; C Warren Olanow; Olivier Rascol; Anette Schrag; Jeanne A Teresi; Jacobus J van Hilten; Nancy LaPelle Journal: Mov Disord Date: 2008-11-15 Impact factor: 10.338
Authors: Andrew Hooyman; Joshua S Talboom; Matthew D DeBoth; Lee Ryan; Matthew J Huentelman; Sydney Y Schaefer Journal: Dev Neuropsychol Date: 2021-10-06 Impact factor: 2.113
Authors: Geneviève N Olivier; Christopher S Walter; Serene S Paul; Leland E Dibble; Sydney Y Schaefer Journal: Motor Control Date: 2021-05-13 Impact factor: 1.422
Authors: Jian Han; Pragya Nepal; Anuoluwapo Odelade; Frederick D Freely; Destiny M Belton; Joseph L Graves; Antoniette M Maldonado-Devincci Journal: Front Nutr Date: 2021-01-20
Authors: Jennapher Lingo VanGilder; Cielita Lopez-Lennon; Serene S Paul; Leland E Dibble; Kevin Duff; Sydney Y Schaefer Journal: Front Rehabil Sci Date: 2021-10-22